ClinicalTrials.Veeva

Menu
R

Retina Health Center | Fort Myers, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

APL-2
KSI-301
Pegcetacoplan
Lampalizumab
Zimura
Ranibizumab
Metformin
Squalamine Lactate
Pegaptanib Sodium
Abicipar Pegol

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 17 total trials

An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD (GALE)

This is a phase 3, open-label, multicenter, extension study to evaluate the long-term safety and efficacy of pegcetacoplan (APL-2) in subjects with g...

Active, not recruiting
Geographic Atrophy Secondary to Age-related Macular Degeneration
Drug: PEGCETACOPLAN (APL-2)

Trial sponsors

A
Roche logo
Kodiak Sciences logo
Allergan logo
E
G
I
N
O
University of California San Francisco (UCSF) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems